The US FDA has issued a safety communication regarding investigational FMT, warning that there is a risk of serious infection caused by the transfer of multidrug-resistant organisms.
The Ministry of Health and WHO have reported the first case of Ebola confirmed in Uganda during the outbreak in neighbouring Democratic Republic of the Congo.
A study has revealed genetic variants associated with differing levels of protective antibodies produced after routine immunizations.
A global genomic survey of Streptococcus pneumoniae has identified 621 strains across 50 countries and has highlighted how the bacteria can evolve in response to vaccination.
Researchers from the Japanese National Institute of Infectious Disease have identified the American subtype of Zika as the most virulent for each of the contributing characteristics tested, when compared with Pacific and Southeast Asian subtypes.
A report analyzing the prevalence and incidence of chlamydia, gonorrhea, trichomoniasis and syphilis for 2016 has reported that rates of these four curable sexually transmitted infections remain high, estimating 376.4 million cases in 2016.
Innate lymphoid cells, a relatively newly discovered class of immune cells, play a pivotal role in controlling early tuberculosis infection, according to new research.
New research has assessed a genetically engineered fungus for the control of malaria mosquitoes in the first semi-field trial, demonstrating that populations were reduced by more than 99%.
Take a look at this month’s industry headlines including US FDA approvals for Mavyret (hepatitis C) and Dengvaxia, a rejection for Contepo and profits for Gilead Sciences.
Over 800,000 individuals will be vaccinated against cholera in North Kivu, Democratic Republic of Congo, as the area suffers an unprecedented combination of epidemics.
